316 related articles for article (PubMed ID: 8431762)
1. Binding of secreted human neuroblastoma proteoglycans to the Alzheimer's amyloid A4 peptide.
Buée L; Ding W; Delacourte A; Fillit H
Brain Res; 1993 Jan; 601(1-2):154-63. PubMed ID: 8431762
[TBL] [Abstract][Full Text] [Related]
2. Binding of vascular heparan sulfate proteoglycan to Alzheimer's amyloid precursor protein is mediated in part by the N-terminal region of A4 peptide.
Buée L; Ding W; Anderson JP; Narindrasorasak S; Kisilevsky R; Boyle NJ; Robakis NK; Delacourte A; Greenberg B; Fillit HM
Brain Res; 1993 Nov; 627(2):199-204. PubMed ID: 8298962
[TBL] [Abstract][Full Text] [Related]
3. Abeta(1-40) prevents heparanase-catalyzed degradation of heparan sulfate glycosaminoglycans and proteoglycans in vitro. A role for heparan sulfate proteoglycan turnover in Alzheimer's disease.
Bame KJ; Danda J; Hassall A; Tumova S
J Biol Chem; 1997 Jul; 272(27):17005-11. PubMed ID: 9202014
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-1 and nerve growth factor induce hypersecretion and hypersulfation of neuroblastoma proteoglycans which bind beta-amyloid.
Leveugle B; Ding W; Buée L; Fillit HM
J Neuroimmunol; 1995 Jul; 60(1-2):151-60. PubMed ID: 7642743
[TBL] [Abstract][Full Text] [Related]
5. Differential binding of vascular cell-derived proteoglycans (perlecan, biglycan, decorin, and versican) to the beta-amyloid protein of Alzheimer's disease.
Snow AD; Kinsella MG; Parks E; Sekiguchi RT; Miller JD; Kimata K; Wight TN
Arch Biochem Biophys; 1995 Jun; 320(1):84-95. PubMed ID: 7793988
[TBL] [Abstract][Full Text] [Related]
6. Localization of heparan sulfate glycosaminoglycan and proteoglycan core protein in aged brain and Alzheimer's disease.
Su JH; Cummings BJ; Cotman CW
Neuroscience; 1992 Dec; 51(4):801-13. PubMed ID: 1488123
[TBL] [Abstract][Full Text] [Related]
7. The role of heparan sulfate proteoglycans in the pathogenesis of Alzheimer's disease.
Small DH; Williamson T; Reed G; Clarris H; Beyreuther K; Masters CL; Nurcombe V
Ann N Y Acad Sci; 1996 Jan; 777():316-21. PubMed ID: 8624106
[TBL] [Abstract][Full Text] [Related]
8. Binding of heparan sulfate glycosaminoglycan to beta-amyloid peptide: inhibition by potentially therapeutic polysulfated compounds.
Leveugle B; Scanameo A; Ding W; Fillit H
Neuroreport; 1994 Jun; 5(11):1389-92. PubMed ID: 7522615
[TBL] [Abstract][Full Text] [Related]
9. Affinity purification of proteoglycans that bind to the amyloid protein precursor of Alzheimer's disease.
Williamson TG; Nurcombe V; Beyreuther K; Masters CL; Small DH
J Neurochem; 1995 Nov; 65(5):2201-8. PubMed ID: 7595508
[TBL] [Abstract][Full Text] [Related]
10. Amyloid beta protein precursor is possibly a heparan sulfate proteoglycan core protein.
Schubert D; Schroeder R; LaCorbiere M; Saitoh T; Cole G
Science; 1988 Jul; 241(4862):223-6. PubMed ID: 2968652
[TBL] [Abstract][Full Text] [Related]
11. Proteoglycan-mediated inhibition of A beta proteolysis. A potential cause of senile plaque accumulation.
Gupta-Bansal R; Frederickson RC; Brunden KR
J Biol Chem; 1995 Aug; 270(31):18666-71. PubMed ID: 7629198
[TBL] [Abstract][Full Text] [Related]
12. Novel glycosaminoglycan precursors as anti-amyloid agents part II.
Kisilevsky R; Szarek WA
J Mol Neurosci; 2002; 19(1-2):45-50. PubMed ID: 12212792
[TBL] [Abstract][Full Text] [Related]
13. Pathological alterations of the cerebral microvasculature in Alzheimer's disease and related dementing disorders.
Buée L; Hof PR; Bouras C; Delacourte A; Perl DP; Morrison JH; Fillit HM
Acta Neuropathol; 1994; 87(5):469-80. PubMed ID: 8059599
[TBL] [Abstract][Full Text] [Related]
14. Interaction between Alzheimer's disease beta A4 precursor protein (APP) and the extracellular matrix: evidence for the participation of heparan sulfate proteoglycans.
Cáceres J; Brandan E
J Cell Biochem; 1997 May; 65(2):145-58. PubMed ID: 9136074
[TBL] [Abstract][Full Text] [Related]
15. A cell-surface heparan sulfate proteoglycan mediates neural cell adhesion and spreading on a defined sequence from the C-terminal cell and heparin binding domain of fibronectin, FN-C/H II.
Haugen PK; Letourneau PC; Drake SL; Furcht LT; McCarthy JB
J Neurosci; 1992 Jul; 12(7):2597-608. PubMed ID: 1613550
[TBL] [Abstract][Full Text] [Related]
16. pH-dependent binding of synthetic beta-amyloid peptides to glycosaminoglycans.
Brunden KR; Richter-Cook NJ; Chaturvedi N; Frederickson RC
J Neurochem; 1993 Dec; 61(6):2147-54. PubMed ID: 8245966
[TBL] [Abstract][Full Text] [Related]
17. High affinity interactions between the Alzheimer's beta-amyloid precursor proteins and the basement membrane form of heparan sulfate proteoglycan.
Narindrasorasak S; Lowery D; Gonzalez-DeWhitt P; Poorman RA; Greenberg B; Kisilevsky R
J Biol Chem; 1991 Jul; 266(20):12878-83. PubMed ID: 1906461
[TBL] [Abstract][Full Text] [Related]
18. Collagen XVIII: a novel heparan sulfate proteoglycan associated with vascular amyloid depositions and senile plaques in Alzheimer's disease brains.
van Horssen J; Wilhelmus MM; Heljasvaara R; Pihlajaniemi T; Wesseling P; de Waal RM; Verbeek MM
Brain Pathol; 2002 Oct; 12(4):456-62. PubMed ID: 12408231
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the high affinity heparin binding site of the Alzheimer's disease beta A4 amyloid precursor protein (APP) and its enhancement by zinc(II).
Multhaup G; Mechler H; Masters CL
J Mol Recognit; 1995; 8(4):247-57. PubMed ID: 8588942
[TBL] [Abstract][Full Text] [Related]
20. Identification in immunolocalization of a new class of proteoglycan (keratan sulfate) to the neuritic plaques of Alzheimer's disease.
Snow AD; Nochlin D; Sekiguichi R; Carlson SS
Exp Neurol; 1996 Apr; 138(2):305-17. PubMed ID: 8620929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
